AstraZeneca Is Hopeful Antibody Cocktail Will Work On New Coronavirus Variant

AstraZeneca Is Hopeful Antibody Cocktail Will Work On New Coronavirus Variant

Pharmaceutical company AstraZeneca stated on Friday that it’s hopeful their antibody cocktail will still be effective against the new COVID-19 variant that is starting to spread around South Africa, and noted they are starting to examine whether the variant is resistant to their vaccine.

“As with any new emerging variants, we are looking into B.1.1.529 to understand more about it and the impact on the vaccine,” AstraZeneca went on to say in a statement, going on to add that it was conducting research in Botswana and Eswatini to gather data.

“We are also testing our long-acting antibody combination AZD7442 against this new variant and are hopeful AZD7442 will retain efficacy since it comprises two potent antibodies with different and complementary activities against the virus,” the company stated.

Well, seeing as how the previous vaccines haven’t really been able to provide a whole lot of protection against the spread of the coronavirus — just look at all the breakthrough cases — it seems highly unlikely that this one will be able to provide a whole lot of protection against a brand new variant of the illness.

take our poll - story continues below

Did SCOTUS make the right decision on medical mandates for large businesses?

  • Did SCOTUS make the right decision on medical mandates for large businesses?  

  • This field is for validation purposes and should be left unchanged.
Completing this poll grants you access to Ken Blackwell updates free of charge. You may opt out at anytime. You also agree to this site's Privacy Policy and Terms of Use.

But hey, this will provide companies like Pfizer with an excuse to continue requesting all of us to get more and more booster shots, right? A new variant is like a present on Christmas for these people.

Source: Newsmax